Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The eradication rate of standard quadruple therapy has become less successful due to low
compliance and high resistance to the antibiotics. Therefore, it is necessary to develop new
treatment strategies that increase the eradication rate and reduce adverse effects. The aims
of this prospective study is to investigate the efficacy of Saccharomyces Boulardii sachets
for eradication of Hp, compared with standard quadruple therap.
Phase:
N/A
Details
Lead Sponsor:
Huazhong University of Science and Technology
Collaborators:
Anlu Puai Hospital Hubei Aerospace Hospital The third people's Hospital of Hubei Province Wuhan Pu-Ai Hospital Wuhan Union Hospital, China Wuhan University Xiaogan Central Hospital Xiaogan First People's Hospital